OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will give a corporate presentation at the Rodman & Renshaw 16th Annual Global Investment Conference being held at the New York Palace Hotel in New York City. Transgenomic will present on Wednesday, September 10, 2014 at 11:15 am ET. Transgenomic Chief Executive Officer Paul Kinnon and Chief Financial Officer Mark Colonnese will participate.
Help employers find you! Check out all the jobs and post your resume.
